Global Market Study on Injectable Nanomedicines: Rapid Adoption of Injectable Nano-formulations in Eradicating Drug-resistant Cancers to Boost Sales


Injectable Nanomedicines  Market
  • Published On : Dec-2018 |
  • Pages : 173 Pages |
  • Format : Injectable Nanomedicines  Market Injectable Nanomedicines  Market Injectable Nanomedicines  Market Injectable Nanomedicines  Market

Reduced side effects of targeted therapies propel demand for injectable nanomedicines

Nanotechnology provides a better safety profiling against drugs with high toxicity. Use of nanotechnology in medicines, specifically drug delivery, is set to increase rapidly. While formulating injectable nanomedicines various strategies can be used to improve the drug delivery and efficacy, e.g. enabling higher therapeutic levels at a target site at lower doses. The injectable nanomedicines release the drug at the targeted site, and allow accumulation of the drug at the site of action. Bing with ligands increases therapeutic efficacy of injectable nanomedicines enhancing active targeting. Better disease management with targeted drug delivery is estimated to lead to higher demand for injectable nanomedicines.

Technological advancements in liposomal drug delivery systems favor development of injectable nanomedicines  

Design & shape of nanoparticles are gaining major research traction leading to development of better injectable nanomedicines. For instance, liposomal technologies are currently used by key drug manufacturers for extended-release drug delivery thereby reducing dosages. These include DepoFoam TM Technology, Non-PEGylated Technology (NPL) and others. These technologies improve patient drug adherence through reduced dosing and lesser side effects. Furthermore, rapid adoption of new and complex technologies for developing irreplicable drugs to sustain competition is a factor expected to support revenue growth of injectable nanomedicines market over the forecast period.

Emergence of academia as the primary organization for performing basic research boosts new product development

A collaboration between academia and pharmaceutical industry is helping the latter to garner higher profits. According to the U.S. National Science Foundation’s 2012 report, 56% of basic research conducted in the U.S. is carried out in academia, whereas 61% of all applied research and 87% of development happens in companies. Scientific and technological expertise coupled with strong academic research ensures better drug development. This factor is expected to boost the injectable nanomedicines industry favorably with faster market outreach.

Limited number of sterile manufacturing facilities hampers the quality of injectable nanomedicines

Globally limited cGMP certified facilities to manufacture complex injectable nanomedicines dampen market’s revenue outlook. Manufacturing of sterile drugs is a critical quality attribute (CQA), as procedural non-conformity may lead to microbial contamination and serious adverse drug reactions (ADRs), including death. Injectable nanomedicines involve the use of nanotechnology for the benefit of human health. Thus, it is very important for manufacturers to develop a suitable sterile manufacturing facility for manufacturing injectable nanomedicines.

Increasing funding on nanomedicine development is expected to fuel the growth of injectable nanomedicines market

Funding on nanomedicines development by governments is steadily increasing, which is attracting more commercialization and development interests from drug makers, making the market more competitive. In this regard, the U.S. Federal Authorities have provided funding worth US$ 1.4 Bn under the National Nanotechnology Initiative, conforming the growing importance and interest on nanomedicines. The growing use of nanomedicines in drug discovery is a major factor expected to drive the revenue growth of the global injectable nanomedicines market over the forecast period.

injectable-nanomedicines-market.jpg

Competitive Landscape

The competition section of the report features profiles of key players operating in the injectable nanomedicines market based on their market share, product offerings, and differential product marketing strategies. Few key players featured in injectable nanomedicines market report include Merck KGaA, Amgen Inc., Pfizer Inc., Lupin, Janssen Biotech Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pacira Pharmaceuticals Inc., Celgene Corporation and  Bausch & Lomb Incorporated. These companies offer a wide range of injectable nanomedicines. Emerging players operating in the injectable nanomedicines market are majorly focusing on new marketing strategies in order to expand their product footprint in the global injectable nanomedicines market. Major players in the injectable nanomedicine market are investing in R&D for development of innovative nanomedicines, currently there are several injectable nanomedicines under clinical trials and are expected to launch in recent years which is likely to upsurge the competition in injectable nanomedicine market.

Definition

Nanomedicines are drugs, or, biologics that incorporate nanoparticles of 10 to 1,000 nm size in order to achieve either specific site targeting, lesser toxic effects, or improved efficacy of therapeutic or imaging agents in vivo. Nanomedicines are diverse in terms of composition and shape. Nanomedicines are likely to be complex combination products. Mostly, they are administered orally or intravenously, the injectable nanomedicines are more pure soluble formulations capable of delivering the drug in smaller volumes.  

About the Report

The report on injectable nanomedicines market offers a comprehensive evaluation of the business opportunities in the injectable nanomedicines market along with insights on the injectable nanomedicines regulatory scenarios, competition blueprint, pipeline assessment, epidemiology study, list of key distributors and suppliers in the injectable nanomedicines market for the duration from 2018 to 2026.

Segmentation

The report offers a comprehensive taxonomy of the injectable nanomedicines market on the basis of drug type, application, end user and region. On the basis of drug type, the global injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals, polymeric nanoparticles, metallic nanoparticles, Mesoporous silica nanoparticles and others. On the basis of applications, the global injectable nanomedicines market has been segmented into cancer, central nervous system disease, cardiovascular disease, infection control, inflammatory disease and others. On the basis of end user the global injectable nanomedicines market has been segmented into hospitals, ambulatory surgical center, clinics, specialized drugs R&D institutes and managed care organizations.  From a geographical perspective, the injectable nanomedicines market has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA).

Additional Questions Answered

Some of the additional questions addressed in this report on injectable nanomedicines market-

  • What is the revenue potential of injectable nanomedicines market across regions of North America and Europe?
  • Who are the key competitors in the injectable nanomedicines market and what are their portfolios?
  • What are the major challenges influencing the growth of the injectable nanomedicines market?
  • How is intervention from regulatory authorities shaping the injectable nanomedicines market growth?

Research Methodology

The injectable nanomedicines market has been estimated based on the supply-demand approach. A triangulation methodology is adopted to derive the Injectable nanomedicines market size, which is primarily based on overall expenditure on the basis of disease epidemiology, life science research and R&D funding to obtain precise market estimations and insights on life science and biotechnology associated services, products, technologies and applications. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases).

A recent market study published by the company – “Injectable nanomedicines: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026”, consists a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historic as well as current growth parameters of the injectable nanomedicines market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the injectable nanomedicines market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the injectable nanomedicines in the upcoming years. The report provides detailed information about the current and future growth prospects of the injectable nanomedicines market in the most comprehensive way for better understanding of the readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the injectable nanomedicines market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the injectable nanomedicines market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the injectable nanomedicines in this chapter, which will help them to understand the basic information about the injectable nanomedicines market dynamics, regulatory scenarios, pipeline assessment, disease epidemiology, reimbursement scenarios, and list of the key participants included in the report.

Chapter 3 – Global Injectable nanomedicines Market Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By Drug Type

Based on the drug type, the injectable nanomedicines market is segmented into liposomes, micelles, nanocrystals, polymeric nanoparticles and metallic nanoparticles, mesoporous silica nanoparticles and others.  In this chapter, readers can find information about key trends and developments in the injectable nanomedicines market and market attractive analysis based on the type of drug products.  

Chapter 4 – Global Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By Application Type

Based on the disease indication, the injectable nanomedicines market is segmented into cancer, central nervous system disease, cardiovascular disease, infection control, inflammatory disease and others. In this chapter, readers can find information about key trends and developments in the injectable nanomedicines market and market attractive analysis based on application type.

Chapter 5 – Global Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By End user

Based on the end user, the injectable nanomedicines market is segmented into hospital, ambulatory surgical centers, clinics, specialized drugs R&D institutes, managed care organizations. In this chapter, readers can find information about key trends and developments in the injectable nanomedicines market and market attractive analysis based on end user.

Chapter 6 – Global Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By Region

This chapter explains how the injectable nanomedicines market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Chapter 7 – North America Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

This chapter includes detailed analysis of the growth of the North America injectable nanomedicines market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on drug type, application, end user and countries of injectable nanomedicines market in North America.

Chapter 8 – Latin America Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

Readers can find detailed information about factors such as, regulatory scenarios, and regional trends that are impacting the growth of the Latin America injectable nanomedicines market. This chapter also includes the growth prospects of the injectable nanomedicines market in leading LATAM countries such as Brazil, Mexico and Rest of the Latin America.

Chapter 9 – Europe Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

Important growth prospects of the injectable nanomedicines market based on its product types, form, and applications in several European countries, such as EU4, the U.K., BENELUX, Nordic, and Rest of Europe.

Chapter 10 – APAC Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

Great China, India, ASEAN, Australia and New Zealand are the leading countries in the APAC region that are the prime subject of assessment to obtain growth prospects of the APAC injectable nanomedicines market in this chapter. Readers can find thorough information about the growth parameters of the APAC injectable nanomedicines market during the period 2018-2026.

Chapter 11 – MEA Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

This chapter provides information on how the injectable nanomedicines market will grow in the major countries in MEA region, such as GCC Countries, Turkey, Iran, Israel, and South Africa, during the period 2018-2026.

Chapter 12 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the injectable nanomedicines market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. The players featured in the report include Merck & Co, Inc., Amgen Inc., Pfizer Inc., Lupin, Janssen Biotech Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pacira Pharmaceuticals Inc., Celgene Corporation and  Bausch & Lomb Incorporated.

Chapter 13 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 14 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the injectable nanomedicines market.

Companies covered in Injectable Nanomedicines Market

Company Profiles

  • Merck & Co., Inc.
  • Lupin
  • Pacira Pharmaceuticals Inc.
  • Celgene Pharmaceutical Co. Ltd.
  • Amgen, Inc.
  • Janssen Biotech Inc. (Sub. Johnson & Johnson Services, Inc.)
  • Pfizer Inc.
  • Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Bausch & Lomb Incorporated.
  • Others.

Injectable Nanomedicines Market

Back To Top